Stay updated on Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial page
- Check3 days agoChange DetectedRemoved the 'Lung cancer' keyword and the 'MedlinePlus Genetics' entry from the related topics section. The related topics header was also removed, reducing cross-links to external resources.SummaryDifference0.2%

- Check11 days agoChange DetectedExpanded the MedlinePlus related topics to include Lung cancer and MedlinePlus Genetics, broadening the educational resources linked from the study page.SummaryDifference0.2%

- Check18 days agoChange DetectedThe page shows a new site revision label (Revision: v3.5.4) alongside removals of certain navigation topics (Lung cancer, related topics:, MedlinePlus Genetics) and an older revision note (Revision: v3.5.3); these are metadata updates to the site and do not affect the study data.SummaryDifference0.2%

- Check25 days agoNo Change Detected
- Check33 days agoChange DetectedAdded Lung cancer as a topic tag and MedlinePlus Genetics as a related topic; updated the page revision to v3.5.3, replacing v3.5.2.SummaryDifference0.2%

- Check47 days agoChange DetectedLung cancer topic added and related topic MedlinePlus Genetics. Page revision updated from v3.5.0 to v3.5.2.SummaryDifference0.2%

- Check54 days agoChange DetectedRemoved the Lung cancer keyword from the Study Basics section. Removed the MedlinePlus Genetics related topics.SummaryDifference0.2%

Stay in the know with updates to Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Epigenetic Drugs in Lung Cancer Clinical Trial page.